Real estate firm advises asset managers on major warehouse letting in Swadlincote

Garrison Real Estate recently advised asset management firm Farran Investments in the letting of a 142,386 sq ft warehouse in Swadlincote – triggering a large-scale refurbishment of the site.

The South Derbyshire-based location, called Tetron142, has been let to international pharmaceutical manufacturers Brunel Healthcare Manufacturing Limited for expansion of its UK business.

Farran Investments has implemented a comprehensive refurbishment programme at the site and shortly after completion agreed terms on a new 15-year lease with Brunel, a long established business in Swadlincote.

Tom Donnachie, senior asset manager at Farran Investments, said: “We are delighted to have let Tetron142 to Brunel Healthcare, providing them with a high-quality HQ warehouse facility building to support their expansion in the area.

“The letting is a direct result of our capital investment to upgrade the building, and the strategy to enhance assets within our portfolio. We are delighted to support Brunel HealthCare’s expansion in the area and look forward to seeing them increase their UK growth in the coming years.”

John Sambrooks, Partner at Garrison Real Estate, which alongside JLL and Savills advised Farran Investments on the deal, said: “Tetron142 is the perfect building for Brunel to accelerate their growth and expansion of their operations within Swadlincote.

“The building provides a modern and well specified building following the recent refurbishment. We are very pleased to have supported Farran Investments to secure a tenant on a long-term lease and we wish Brunel continued success with their future plans.”

John Hackett, CEO at Brunel Healthcare, said “We’ve been manufacturing vitamins and healthfood supplements in the Swadlincote area since the late 1800s.

“We have experienced rapid growth over the last 15 years, and the lease of Tetron142 is an important part of our next chapter, with increasing growth opportunities for us, both at home, and in international markets.”

Brunel Healthcare were represented by retained adviser Tim Harries of Tim Harries & Partners.

Pictured from left to right: John Sambrooks, Mat Woodings from Brunel Healthcare, and Tom Donnachie from Farran Investments.